A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

It’s only the second time the World Health Assembly has adopted a health treaty, but key details of this Pandemic Agreement ...

Ken Hall takes a closer look at GSK after the FTSE 100 pharmaceutical giant's positive first quarter earnings update.

“I am excited to welcome AstraZeneca to our association, a company with a long history of tackling big challenges and improving people’s lives,” PhRMA CEO Stephen Ubl said in the statement.

These investments have also included the expansion of AstraZeneca’s Global Research and Development (R&D) Hub and the creation of a new Alexion R&D Hub focused on rare disease research. With a 70-year ...

Investors in AstraZeneca plc (Symbol: AZN) saw new options become available today, for the June 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AZN ...

At such a critical moment in US history, we need reporters on the ground ... paid for by those who can afford it. AstraZeneca has doubled down on plans to grow its US business as it braces ...

Founded in 1900, the Oswaldo Cruz Foundation has made fundamental contributions to the basic understanding of infectious disease and public health. Lise Alves reports.

A warm welcome to AstraZeneca's first quarter 2025 Presentation ... the prevention of cardiovascular events in patients with a history of atherosclerotic cardiovascular disease and those at ...

The new bill extends previous legislation, codifying how clinics can provide access to drugs that have only been through ...